The Francis Crick Institute
fimmu-12-639174 (1).pdf (1.79 MB)

Evaluation of host serum protein biomarkers of tuberculosis in sub-Saharan Africa.

Download (1.79 MB)
journal contribution
posted on 2021-03-24, 11:29 authored by Thomas C Morris, Clive J Hoggart, Novel N Chegou, Martin Kidd, Tolu Oni, Rene Goliath, Katalin A Wilkinson, Hazel M Dockrell, Lifted Sichali, Louis Banda, Amelia C Crampin, Neil French, Gerhard Walzl, Michael Levin, Robert J Wilkinson, Melissa S Hamilton, ILULU Consortium
Accurate and affordable point-of-care diagnostics for tuberculosis (TB) are needed. Host serum protein signatures have been derived for use in primary care settings, however validation of these in secondary care settings is lacking. We evaluated serum protein biomarkers discovered in primary care cohorts from Africa reapplied to patients from secondary care. In this nested case-control study, concentrations of 22 proteins were quantified in sera from 292 patients from Malawi and South Africa who presented predominantly to secondary care. Recruitment was based upon intention of local clinicians to test for TB. The case definition for TB was culture positivity for Mycobacterium tuberculosis; and for other diseases (OD) a confirmed alternative diagnosis. Equal numbers of TB and OD patients were selected. Within each group, there were equal numbers with and without HIV and from each site. Patients were split into training and test sets for biosignature discovery. A nine-protein signature to distinguish TB from OD was discovered comprising fibrinogen, alpha-2-macroglobulin, CRP, MMP-9, transthyretin, complement factor H, IFN-gamma, IP-10, and TNF-alpha. This signature had an area under the receiver operating characteristic curve in the training set of 90% (95% CI 86-95%), and, after adjusting the cut-off for increased sensitivity, a sensitivity and specificity in the test set of 92% (95% CI 80-98%) and 71% (95% CI 56-84%), respectively. The best single biomarker was complement factor H [area under the receiver operating characteristic curve 70% (95% CI 64-76%)]. Biosignatures consisting of host serum proteins may function as point-of-care screening tests for TB in African hospitals. Complement factor H is identified as a new biomarker for such signatures.


Crick (Grant ID: 10218, Grant title: Wilkinson, R FC001218)


Usage metrics

    The Francis Crick Institute



    Ref. manager